CNS Pharmaceuticals (CNSP) CEO converts 4,750 RSUs to stock
Rhea-AI Filing Summary
Levin Rami reported disposition transactions in this Form 4 filing.
CNS Pharmaceuticals, Inc. executive Rami Levin reported the vesting and conversion of 4,750 Restricted Stock Units into 4,750 shares of Common Stock on August 14, 2026. Each RSU represents a contingent right to one share of common stock. The RSUs stem from a 19,000-unit grant made on January 1, 2026, which vests 25% at six months, 25% at twelve months, and the remaining 50% in twelve quarterly installments, subject to continued employment. Following this transaction, Levin holds 14,250 RSUs and 4,750 shares of Common Stock directly, and the filing indicates these transactions were not made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,750 shares
Net Sell
2 txns
Insider
Levin Rami
Role
CEO and President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F3, F2 | 4,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,750 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 14,250 shares (Direct);
Common Stock — 4,750 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of Company common stock.
- F2. On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.
- F3. Issued in connection with the reporting person's employment with the Company.
Key Figures
RSUs converted: 4,750 units
Common shares held after: 4,750 shares
RSUs held after: 14,250 units
+3 more
6 metrics
RSUs converted
4,750 units
Restricted Stock Units converted into Common Stock on August 14, 2026
Common shares held after
4,750 shares
Direct Common Stock holdings following the August 14, 2026 transaction
RSUs held after
14,250 units
Restricted Stock Units remaining from the January 1, 2026 grant after conversion
Original RSU grant
19,000 units
Restricted Stock Units granted to Rami Levin on January 1, 2026
Initial vesting portions
25% + 25%
First and second tranches of RSU vesting at six and twelve months after January 1, 2026
Remaining vesting pattern
50% in 12 installments
Final 50% of the 19,000 RSUs vesting in twelve quarterly installments
Key Terms
Restricted Stock Units, contingent right, vesting, quarterly installments, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one share of Company common stock"
vesting financial
"restricted stock units, vesting as follows: 25% on the six-month anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
quarterly installments financial
"and the remaining 50% in twelve quarterly installments thereafter"
continued employment financial
"thereafter, subject to the reporting person's continued employment on each vesting date"
Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.
FAQ
What did CNSP CEO Rami Levin report in this Form 4 filing?
Rami Levin reported the vesting and conversion of 4,750 Restricted Stock Units into 4,750 shares of CNSP Common Stock on August 14, 2026, as part of his equity compensation package granted on January 1, 2026.
How many Restricted Stock Units does CNSP CEO Rami Levin hold after this transaction?
After the reported transaction, Rami Levin holds 14,250 Restricted Stock Units. These remaining RSUs are from an original 19,000-unit grant made on January 1, 2026, which vests over time subject to his continued employment.
What is the vesting schedule for Rami Levin’s 19,000 CNSP Restricted Stock Units?
The 19,000 RSUs granted on January 1, 2026 vest 25% at the six-month anniversary, 25% at the twelve-month anniversary, and the remaining 50% in twelve quarterly installments, conditioned on Rami Levin’s continued employment on each vesting date.
Were Rami Levin’s CNSP Form 4 transactions under a Rule 10b5-1 trading plan?
No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmatively marked, and there is no footnote stating that the reported RSU conversion and related transactions were executed pursuant to a Rule 10b5-1 trading plan.
Why were Rami Levin’s CNSP Restricted Stock Units issued?
The filing states that the Restricted Stock Units were issued in connection with Rami Levin’s employment with CNS Pharmaceuticals. They form part of his equity-based compensation and vest over time, subject to his continued employment with the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
